Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease Diagnosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02423200
What this trial is testing

Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Who this might be right for
Alzheimer's Disease
EIP Pharma Inc 16
Post-approval studies (Phase 4)UnknownNCT00306124
What this trial is testing

Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentHealthy
University Hospital Muenster 120
Testing effectiveness (Phase 2)Study completedNCT00785759
What this trial is testing

Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers

Who this might be right for
Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
GE Healthcare 78
Post-approval studies (Phase 4)Ended earlyNCT00369603
What this trial is testing

Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Duke University 4
Early research (Phase 1)Study completedNCT06774261
What this trial is testing

Phenserine on the Alzheimer's Treatment Horizon, Study 1

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Helse Stavanger HF 16
Not applicableLooking for participantsNCT05081596
What this trial is testing

A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD

Who this might be right for
DepressionPainCognitive Impairment
Weill Medical College of Cornell University 100
Not applicableUnknownNCT01421420
What this trial is testing

Alzheimer's Disease Core Center

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentAge-Related Memory Disorders
University of Arizona 900
Early research (Phase 1)Study completedNCT00937846
What this trial is testing

Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study

Who this might be right for
Cognitive Disorders
GlaxoSmithKline 4
Not applicableStudy completedNCT06864910
What this trial is testing

Brain Functional Changes Accompany Modulatory Effects of Transcranial Direct Current Stimulation in Cognitive Impairment

Who this might be right for
Cognitive Impairment
National Institute of Mental Health and Neuro Sciences, India 40
Large-scale testing (Phase 3)Study completedNCT02719327
What this trial is testing

Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid

Who this might be right for
Alzheimer's Disease
VA Office of Research and Development 131
Large-scale testing (Phase 3)Ended earlyNCT02956486
What this trial is testing

A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Co., Ltd. 2,212
Not applicableStudy completedNCT03221894
What this trial is testing

A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Dongzhimen Hospital, Beijing 120
Not applicableEnded earlyNCT02020356
What this trial is testing

Music Therapy in Alzheimer's Disease

Who this might be right for
Alzheimer's Type Dementia
University Hospital, Toulouse 35
Post-approval studies (Phase 4)UnknownNCT02951559
What this trial is testing

SOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies

Who this might be right for
EncephalopathyHIV-encephalopathyAlzheimer Dementia
University of Turin, Italy 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07212062
What this trial is testing

The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab.

Who this might be right for
Alzheimers Disease
Neurology Office of South Florida 60
Not applicableStudy completedNCT04726527
What this trial is testing

Clinical Evaluation of Florbetapir in Primary Progressive Aphasia

Who this might be right for
Primary Progressive AphasiaAlzheimer DiseaseDementia
University of Chicago 48
Not applicableLooking for participantsNCT06703541
What this trial is testing

ADRC Clinical Cohort (Alzheimer's Disease)

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentDementia
Duke University 500
Testing effectiveness (Phase 2)Study completedNCT02813070
What this trial is testing

Comparison of PET Amyloid Imaging in Japanese and Western Subjects

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseHealthy
GE Healthcare 70
Not applicableUnknownNCT05569083
What this trial is testing

PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With Machine Learning

Who this might be right for
Cognitive DeclineMild Cognitive ImpairmentAlzheimer Disease
Azienda Ospedaliero-Universitaria Careggi 350
Early research (Phase 1)WithdrawnNCT03752294
What this trial is testing

A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.

Who this might be right for
Mild Cognitive ImpairmentMild Alzheimer's Disease
University of Rhode Island
Next Page